Get the Stockscreener App
4.21
3.00%
-0.13
Shuttle Pharmaceuticals Holdings Inc stock is traded at $4.21, with a volume of 87,229.
It is down -3.00% in the last 24 hours and down -2.83% over the past month.
Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.
See More
Previous Close:
$4.34
Open:
$4.35
24h Volume:
87,229
Relative Volume:
0.42
Market Cap:
$2.44M
Revenue:
-
Net Income/Loss:
$-7.35M
P/E Ratio:
-9.1522
EPS:
-0.46
Net Cash Flow:
$-5.48M
1W Performance:
+19.26%
1M Performance:
-2.83%
6M Performance:
-80.21%
1Y Performance:
-56.82%
1-Day Range:
$4.00
$4.48
1-Week Range:
$3.29
$4.5992
52-Week Range:
$3.00
$82.50
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Company Profile
Name
Shuttle Pharmaceuticals Holdings Inc
Sector
Phone
(240) 403-4212
Address
401 PROFESSIONAL DRIVE, GAITHERSBURG
Compare SHPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SHPH
Shuttle Pharmaceuticals Holdings Inc
|
4.20 | 2.44M | 0 | -7.35M | -5.48M | -0.46 |
|
RGC
Regencell Bioscience Holdings Ltd
|
9.66 | 303.95B | 0 | -5.87M | -767.30K | -0.45 |
|
ZTS
Zoetis Inc
|
159.60 | 74.39B | 9.29B | 2.52B | 2.28B | 5.57 |
|
HLN
Haleon Plc Adr
|
10.24 | 48.97B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.43 | 47.39B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.02 | 20.17B | 16.54B | -1.64B | 749.00M | -1.45 |
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Latest News
Shuttle Pharmaceuticals says reverse stock split to become effective June 16 - Yahoo Finance
# Shuttle Pharmaceuticals plans 25-for-1 reverse stock split By Investing.com - Investing.com South Africa
Shuttle Pharma Announces Reverse Stock Split Will Become Effective On June 16 - MarketScreener
Shuttle Pharma Announces Reverse Stock Split will Become Effective on June 16, 2025, at 12:01 a.m., Eastern Time - GlobeNewswire
Shuttle Pharma Announces Major 25:1 Reverse Split: Key Details Every Investor Must Know Before June 16 - Stock Titan
# Shuttle Pharmaceuticals plans 25-for-1 reverse stock split - Investing.com
Shuttle Pharmaceuticals Holdings, Inc. Proposes 25-for-1 Reverse Stock Split to Comply with Nasdaq Requirements - Nasdaq
Shuttle Pharma Announces Proposed Reverse Stock Split as Part of Strategic Nasdaq Compliance Initiative - GlobeNewswire
Shuttle Pharma Board Approves Major 25:1 Reverse Split to Maintain Nasdaq Listing - Stock Titan
Pre-market Movers: SHPH, WORX, IOVA, PLRZ... - RTTNews
Shuttle Pharma Appoints George Scorsis Chairman of the Board of Directors - GlobeNewswire
Shuttle Pharma appoints new Chairman to its Board By Investing.com - Investing.com India
Shuttle Pharma appoints new Chairman to its Board - Investing.com Australia
Shuttle Pharma Appoints George Scorsis Chairman Of The Board Of Directors - marketscreener.com
Cancer Treatment Pioneer Shuttle Pharma Taps 25-Year Industry Leader George Scorsis to Drive Growth Strategy - Stock Titan
Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) Sees Significant Increase in Short Interest - Defense World
Savara Inc (NASDAQ:SVRA) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World
Johnson Matthey (LON:JMAT) Stock Price Crosses Above 200 Day Moving Average – Here’s What Happened - Defense World
Invesco WilderHill Clean Energy ETF (NYSEARCA:PBW) Shares Sold by Bank of America Corp DE - Defense World
Shuttle Pharmaceuticals slashes exec salaries by 70% as it fights to preserve cash - The Business Journals
Shuttle Pharmaceuticals Holdings Implements 70% Salary Reduction For ExecutivesSEC Filing - marketscreener.com
Shuttle Pharmaceuticals Announces Major Salary Reductions - TipRanks
SHPH stock plunges to 52-week low of $0.2 amid market challenges - Investing.com India
Shuttle Pharma Provides Corporate Update - citybiz
Shuttle Pharmaceuticals Announces Leadership Changes and Meeting Outcomes - TipRanks
Shuttle Pharma Phase 2 Brain Cancer Trial Shows Promise: 84% Patient Completion Rate Signals Strong Progress - Stock Titan
Pre-market Movers: CNSP, XLO, PLRZ, SGMO... - RTTNews
Why Sable Offshore Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket - Benzinga
Certain Common Stock of Shuttle Pharmaceuticals Holdings, Inc. are subject to a Lock-Up Agreement Ending on 12-MAY-2025. - marketscreener.com
Certain Pre-Funded Warrants of Shuttle Pharmaceuticals Holdings, Inc. are subject to a Lock-Up Agreement Ending on 12-MAY-2025. - marketscreener.com
Shuttle Pharma’s glioblastoma trial reaches halfway mark By Investing.com - Investing.com Nigeria
Why Pinterest Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket - Benzinga
Shuttle Pharma’s glioblastoma trial reaches halfway mark - Investing.com
Shuttle Pharma FDA Orphan-Drug Nears Patient Enrollment Milestone for Phase 2 Clinical Trial - GlobeNewswire
Shuttle Pharmaceuticals Holdings Offers Up To 10,000,000 Shares Of Common Stock - marketscreener.com
Did Shuttle Pharmaceuticals Holdings Inc (SHPH) perform well in the last session? - uspostnews.com
Market Resilience: Shuttle Pharmaceuticals Holdings Inc (SHPH) Finishes Weak at 0.27, Down -8.74 - DWinneX
Renaissance Technologies LLC Purchases 26,808 Shares of CPI Card Group Inc. (NASDAQ:PMTS) - Defense World
Nothing is Better Than Shuttle Pharmaceuticals Holdings Inc (SHPH) stock at the moment - Sete News
Shuttle Pharmaceuticals Holdings Inc [SHPH] moved up 0.12: Why It’s Important - dbtnews.com
Ratio Revelations: Shuttle Pharmaceuticals Holdings Inc (SHPH)’s Financial Metrics in the Spotlight - DWinneX
Small Cap Stock Shuttle Pharmaceuticals Holdings Inc (SHPH) Is A Buy – Analysts - Marketing Sentinel
The Psychology of Shuttle Pharmaceuticals Holdings Inc Inc. (SHPH) Price Performance: Understanding Market Sentiment - investchronicle.com
A review of SHPH’s current quarter earnings predictions - uspostnews.com
Shuttle Pharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025 - GlobeNewswire
Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) Sees Significant Growth in Short Interest - Defense World
Shuttle Pharmaceuticals (NASDAQ:SHPH) Trading Down 16.7% – Here’s Why - Defense World
SHPH stock plunges to 52-week low of $0.33 amid steep annual decline - Investing.com India
Shuttle Pharma files patent for cancer treatment innovation By Investing.com - Investing.com Canada
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.31%
0.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):